James L. Gulley
United States of America
Dr. Gulley is Director of the Medical Oncology Service, Chief of the Genitourinary Malignancies Branch and Head of the Immunotherapy Section at NCI. He is an internationally recognized expert in cancer immunotherapy with a strong interest in prostate cancer. He serves as the principal investigator on several international clinical trials, among which for a prostate cancer vaccine and several trials using immune checkpoint inhibitors.
His research interest in Business and Management